News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,578 Results
Type
Article (44107)
Company Profile (308)
Press Release (662163)
Section
Business (208346)
Career Advice (2078)
Deals (35987)
Drug Delivery (90)
Drug Development (82243)
Employer Resources (170)
FDA (16774)
Job Trends (15139)
News (352473)
Policy (33577)
Tag
Academia (2707)
Alliances (50791)
Alzheimer's disease (1252)
Approvals (16689)
Artificial intelligence (120)
Bankruptcy (354)
Best Places to Work (11727)
Biotechnology (221)
Breast cancer (111)
Cancer (936)
Cardiovascular disease (82)
Career advice (1731)
Cell therapy (210)
Clinical research (64923)
Collaboration (337)
Compensation (169)
COVID-19 (2603)
Data (873)
Diabetes (137)
Diagnostics (6255)
Drug pricing (84)
Earnings (85156)
Employer resources (148)
Events (111651)
Executive appointments (256)
FDA (17224)
Funding (299)
Gene therapy (155)
GLP-1 (572)
Government (4474)
Healthcare (19331)
Infectious disease (2679)
Inflammatory bowel disease (103)
Interviews (320)
IPO (16464)
Job creations (3706)
Job search strategy (1481)
Layoffs (412)
Legal (8116)
Lung cancer (161)
Manufacturing (155)
Medical device (13799)
Medtech (13804)
Mergers & acquisitions (19543)
Metabolic disorders (372)
Neuroscience (1504)
NextGen Class of 2024 (6772)
Non-profit (4601)
Northern California (1223)
Obesity (221)
Opinion (184)
Patents (95)
People (57376)
Phase I (20215)
Phase II (28582)
Phase III (21294)
Pipeline (214)
Postmarket research (2602)
Preclinical (8674)
Radiopharmaceuticals (237)
Rare diseases (182)
Real estate (6044)
Regulatory (22206)
Research institute (2443)
Resumes & cover letters (366)
Southern California (1100)
Startups (3691)
United States (11916)
Vaccines (565)
Weight loss (165)
Date
Today (240)
Last 7 days (855)
Last 30 days (3026)
Last 365 days (36341)
2024 (31030)
2023 (40840)
2022 (52015)
2021 (56663)
2020 (55249)
2019 (48049)
2018 (36219)
2017 (33237)
2016 (32820)
2015 (38862)
2014 (32632)
2013 (27825)
2012 (30007)
2011 (30605)
2010 (28668)
Location
Africa (757)
Arizona (190)
Asia (38856)
Australia (6396)
California (2782)
Canada (1185)
China (210)
Colorado (122)
Connecticut (130)
Europe (84537)
Florida (397)
Georgia (104)
Illinois (316)
Indiana (180)
Kansas (97)
Maryland (526)
Massachusetts (2293)
Michigan (144)
Minnesota (258)
New Jersey (839)
New York (853)
North Carolina (682)
Northern California (1223)
Ohio (129)
Pennsylvania (753)
South America (1144)
Southern California (1100)
Texas (391)
Utah (81)
Washington State (333)
706,578 Results for "aesculap implant systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Aesculap Launches AESCULAP Aicon® RTLS
Aesculap, Inc., a market leader in sterile container systems, has launched AESCULAP Aicon® RTLS, which pairs real-time location service technology with the AESCULAP Aicon® Sterile Container System to help improve the efficiency of Sterile Processing Departments.
April 16, 2024
·
2 min read
FDA
FDA Grants Aesculap Breakthrough Device Designation for the M.scio® Non-Invasive Telemetric Pressure Measurement System
August 27, 2024
·
3 min read
Press Releases
BlueWind Medical Announces Favorable CMS Decision for 2025 Reimbursement Rates for Revi® System’s Implantable Tibial Neuromodulation Therapy
November 4, 2024
·
3 min read
BioForest
MCRA Supports 3D Systems with 510(k) FDA Clearance for VSP PEEK Cranial Implant Device
MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm is pleased to announce its role in the U.S. Food and Drug Administration’s (FDA) 510(k) clearance for 3D Systems’ 3D-printed, patient-specific cranial implant solution — VSP® PEEK Cranial Implant.
June 18, 2024
·
3 min read
Press Releases
New Research from BlueWind Medical Shows Implantable Tibial Neuromodulation (iTNM), such as the Revi® System, as Effective Alternative to Sacral Neuromodulation (SNM) for Overactive Bladder and Urge Urinary Incontinence
October 31, 2024
·
4 min read
Biotech Bay
SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
SI-BONE, Inc. announced the first cases completed with the smaller, 9.5 mm diameter, iFuse Bedrock Granite® Implant.
May 7, 2024
·
3 min read
BioMidwest
Aria CV Announces First Patient Successfully Implanted with Second-Generation Pulmonary Hypertension System
Aria CV, Inc today announced the first patient was implanted with the Gen 2 Aria CV Pulmonary Hypertension System as part of the ASPIRE PH clinical trial at Ascension St. Vincent Cardiovascular Research Institute in Indianapolis, Indiana.
February 27, 2024
·
3 min read
Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies
Sensorion announces that promising new data and analysis results from the SENS-401 following cochlear implantation Phase 2a clinical study will be presented at the 17th International Conference on Cochlear Implants and Other Implantable Technologies taking place on July 10-13, 2024, in Vancouver, Canada.
June 20, 2024
·
5 min read
Biotech Bay
Glucotrack Announces Increased Sensor Longevity for Its Implantable Continuous Blood Glucose Monitor
Glucotrack, Inc. and The Technology Partnership, announced the completion of computational modeling for Glucotrack’s implantable Continuous Blood Glucose Monitor, suggesting sensor longevity beyond three years, a year longer than the Company previously announced.
April 2, 2024
·
5 min read
Genetown
Alcyone Therapeutics Announces First Patient Implanted in PIERRE IDE Clinical Study of the ThecaFlex DRx™ System for Administration of SPINRAZA® (nusinersen)
Alcyone Therapeutics Inc. announced the first patient implanted in the PIERRE pivotal study to evaluate the safety and performance of the ThecaFlex DRx System.
January 3, 2024
·
8 min read
1 of 70,658
Next